246
Views
26
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Assessing the Natural Course of Diabetic Retinopathy: A Population-Based Study in Kinmen, Taiwan

, , , , , , & show all
Pages 327-333 | Received 07 Feb 2006, Accepted 22 May 2006, Published online: 08 Jul 2009

REFERENCES

  • Garg S K, Marshall G, Chase H P, et al. The use of the Markov process in describing the natural course of diabetic retinopathy. Arch Ophthalmol 1990; 108(9)1245–1247, [INFOTRIEVE], [CSA]
  • Diabetic Retinopathy Study Research Group. Invest Ophthalmol Vis Sci 1981; 21(1 Pt 2)1–226, Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy Study Research Group[CSA]
  • Early Treatment Diabetic Retinopathy Study Group. Photocoagulation for diabetic macular edema. ETDRS report number 1. Arch Ophthalmol 1985; 103(12)1796–1806, [CSA]
  • The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. DRVS Report No. 2. Arch Ophthalmol 1985; 103(11)1644–1652, [CSA]
  • The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes 1986; 35(5)530–545, [CSA]
  • Liu W J, Yen M F, Tung T H, et al. Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan. Diabet Med 2003; 20(9)727–733, [INFOTRIEVE], [CROSSREF], [CSA]
  • Vijan S, Hofer T P, Hayward R A. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. J Am Med Assoc 2000; 283(7)889–896, [CROSSREF], [CSA]
  • Javitt J C, Aiello L P. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996; 124(1 Pt 2)164–169, [INFOTRIEVE], [CSA]
  • Dasbach E J, Fryback D G, Newcomb P A, Klein R, Klein B E. Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care 1991; 29(1)20–39, [INFOTRIEVE], [CROSSREF], [CSA]
  • Tung T H, Liu J H, Lee F L, et al. Population-based study of nonproliferative diabetic retinopathy among type 2 diabetic patients in Kinmen, Taiwan. Jpn J Ophthalmol 2006; 50(1)44–52, [INFOTRIEVE], [CROSSREF], [CSA]
  • Tung T H, Chen S J, Liu J H, et al. A community-based follow-up study on diabetic retinopathy among type 2 diabetics in Kinmen. Eur J Epidemiol 2005; 20(4)317–323, [INFOTRIEVE], [CROSSREF], [CSA]
  • Tung T H, Chen S J, Lee F L, et al. A community-based study for the utility values associated with diabetic retinopathy among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract 2005; 68(3)265–273, [INFOTRIEVE], [CROSSREF], [CSA]
  • Chou P, Liao M J, Kuo H S, et al. A population survey on the prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care 1994; 17(9)1055–1058, [INFOTRIEVE], [CSA]
  • World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva 1999
  • Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS Report No. 9. Ophthalmology 1991; 98(Suppl 5)766–785, [CSA]
  • Wilkinson C P, Ferris F L, Klein R E, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110(9)1677–1682, [INFOTRIEVE], [CROSSREF], [CSA]
  • Kalbfleisch D, Lawless J F. The analysis of panel data under a Markov assumption. J Am Stat Assoc 1985; 80: 863–871, [CROSSREF], [CSA]
  • Chen T HH, Kuo H S, Yen M F, et al. Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics 2000; 56(1)167–172, [INFOTRIEVE], [CROSSREF], [CSA]
  • Kuo H S, Chang H J, Chou P, Teng L, Chen T HH. A Markov chain model to assess the efficacy of screening for non-insulin-dependent diabetes mellitus. Int J Epidemiol 1999; 28(2)233–240, [INFOTRIEVE], [CROSSREF], [CSA]
  • Aiello L P, Gardner T W, King G L, et al. Diabetes retinopathy. Diabetes Care 1998; 21(1)143–156, [INFOTRIEVE], [CSA]
  • Hirsch I B. Surveillance for complications of diabetes: don't wait for symptoms before intervening. Postgrad Med 1996; 99(3)147–55, 159–162[INFOTRIEVE], [CSA]
  • Klein R, Klein B EK, Moss S E, Davis M D, DeMets D L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 1989; 107(2)244–249, [INFOTRIEVE], [CSA]
  • British Diabetic Association. Guidelines on the Management of Diabetes in Primary Care. British Diabetic Association, London 1994
  • Clinical Standards Advisory Group. Standard of Clinical Care for People with Diabetes. HMSO, London 1994
  • Eastman R C, Javitt J C, Herman W H, et al. Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care 1997; 20(5)725–734, [INFOTRIEVE], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.